Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to $1.0 million.

  • Fortress Biotech's Depreciation & Amortization (CF) changed negligibly% to $100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $466,000, marking a year-over-year decrease of 62.11%. This contributed to the annual value of $1.0 million for FY2024, which is 53.36% down from last year.
  • According to the latest figures from FY2024, Fortress Biotech's Depreciation & Amortization (CF) is $1.0 million, which was down 53.36% from $2.2 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Depreciation & Amortization (CF) ranged from a high of $3.1 million in FY2022 and a low of $1.0 million during FY2024.
  • Over the past 3 years, Fortress Biotech's median Depreciation & Amortization (CF) value was $2.2 million (recorded in 2023), while the average stood at $2.1 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first rose by 19.67% in 2020, then plummeted by 53.36% in 2024.
  • Over the past 5 years, Fortress Biotech's Depreciation & Amortization (CF) (Yearly) stood at $2.3 million in 2020, then grew by 14.26% to $2.6 million in 2021, then grew by 18.30% to $3.1 million in 2022, then dropped by 28.27% to $2.2 million in 2023, then tumbled by 53.36% to $1.0 million in 2024.